Results 261 to 270 of about 2,218,427 (310)
Some of the next articles are maybe not open access.

New drug development

European Journal of Cancer and Clinical Oncology, 1991
INTRODUCTION AT THE start of the 1990s it is apparent that the evolution of chemotherapy is entering a crucial phase. After the first demonstration of the successful use of anticancer agents in human cancer over 30 years ago, there followed a period of 20 years of clinical research, !argely based on empiricism, which gave rise to some remarkable ...
openaire   +2 more sources

Antituberculosis drugs and new drug development

Current Opinion in Pulmonary Medicine, 2001
Tuberculosis affects more than 8 million people and has serious repercussions on economic, psychologic, and social status. Since its declaration as a global emergency in 1993 by the World Health Organization, significant development in the treatment and control of tuberculosis has been the implementation of the short-course directly observed treatment ...
S, Agrawal   +4 more
openaire   +2 more sources

“Precision” drug development?

Clinical Pharmacology & Therapeutics, 2015
The concept of precision medicine has entered broad public consciousness, spurred by a string of targeted drug approvals, highlighted by the availability of personal gene sequences, and accompanied by some remarkable claims about the future of medicine. It is likely that precision medicines will require precision drug development programs.
openaire   +2 more sources

Neonatal drug development

Early Human Development, 2011
Drug development is crucial to improving the care given to neonates through new and existing medicines. Pressure from regulatory agencies has improved the way in which pharmaceutical companies work with neonates. This provides new opportunities for the neonatal community.
openaire   +2 more sources

Active drug metabolites in drug development

Current Opinion in Pharmacology, 2003
Active drug metabolites discovered during the course of drug development constitute a subset of the larger issue of metabolic drug interactions, but still demand unique consideration from both an efficacy and a safety point of view. Improved technology has allowed better identification and quantification of metabolites, raising new issues to be ...
openaire   +2 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Drug Development

2020
Corina Duda-Seiman   +2 more
  +4 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Drug development

Family & Community Health, 1982
openaire   +2 more sources

Home - About - Disclaimer - Privacy